We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Rapid Blood Test Identifies Pre-Symptomatic Patients with Parkinson’s Disease

By LabMedica International staff writers
Posted on 15 Apr 2025

Currently, no reliable blood test exists for diagnosing Parkinson’s disease. More...

Instead, physicians rely on observing a patient's movements, but this qualitative method has an error rate of 20%-25% and can only be used after the disease has advanced and significant symptoms are present. Another test, involving a spinal tap, cannot track disease progression and is costly and uncomfortable for patients. Now, researchers have developed a new diagnostic test that measures transfer RNA fragments (tRFs) from nucleated red blood cells to identify pre-symptomatic Parkinson’s patients and monitor disease progression.

Researchers at Hebrew University (Jerusalem, Israel) in collaboration with ATED Therapeutics (Greenwich, CT, USA), have developed a simple, reliable, and cost-effective blood test that could revolutionize Parkinson’s diagnosis. This test can accurately identify whether someone is developing Parkinson’s before symptoms even appear. The researchers took a novel approach by analyzing tRFs, which had previously been overlooked in Parkinson’s research, to detect the disease at its earliest stages. Their study revealed a recurring pattern of tRNA fragments in the cerebrospinal fluid of Parkinson’s patients. The researchers identified two key biomarkers with altered patterns, potentially indicating significant biological changes linked to neurodegeneration.

First, they discovered tiny tRFs with a specific pattern based on seven building blocks of RNA and DNA. These tRFs were named RGTTCRA fragments, after the RNA molecules involved in the pattern. They also identified another set of fragments originating from mitochondria, the energy-producing components of cells, which are known to be damaged in Parkinson’s disease. Parkinson’s patients had higher levels of RGTTCRA-tRFs and lower levels of mitochondrial tRFs compared to healthy individuals. By measuring the ratio of these biomarkers, the test can differentiate pre-symptomatic Parkinson’s patients from healthy individuals. The test uses the same lab technique employed in COVID-19 diagnostics, measuring the amounts of each RNA fragment in a blood sample and calculating their ratio.

To validate their discovery, the researchers tested blood samples from 60 Parkinson’s patients and 60 healthy controls. The patients, who were experiencing early symptoms such as loss of smell and difficulty sleeping, had not yet developed the hallmark symptoms like tremors. The researchers analyzed the ratio between RGTTCRA-tRFs and mitochondrial tRFs and used machine learning to predict which participants were pre-symptomatic Parkinson’s patients and which were healthy. Published in the journal Nature Aging, the results showed that the blood test correctly identified the disease in about 86% of cases, outperforming current diagnostic methods. Furthermore, the test can also measure the effects of deep brain stimulation (DBS), a common treatment for Parkinson’s. The researchers are currently in talks with pharmaceutical companies to conduct the test on a larger and more diverse cohort, a necessary step for FDA approval.


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated Biochemical Analyzer
iBC 900
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Microbiology

view channel
Image: The groundbreaking salmonella antimicrobial resistance prediction platform has demonstrated 95% accuracy (Photo courtesy of Yujie You et al., DOI: 10.1016/j.eng.2025.01.013)

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance

Antimicrobial-resistant Salmonella strains are a growing public health concern due to the overuse of antimicrobials and the rise of genetic mutations. Accurate prediction of resistance is crucial for effective... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.